Search research articles
Contact Us
Filters
Showing results (161-170 of 188) with videos related to
Page
of 19
Sort By:
Circulation
|
September 1, 1995
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators
G A Lamas, G C Flaker, G Mitchell, et al.
The American Journal of Cardiology
|
March 15, 1995
Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels
F M Sacks, J L Rouleau, L A Moye, et al.
Circulation
|
October 1, 1986
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion
R G McKay, M A Pfeffer, R C Pasternak, et al.
Circulation
|
December 13, 1997
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial
M St John Sutton, M A Pfeffer, L Moye, et al.
Circulation
|
October 1, 1994
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators
J D Rutherford, M A Pfeffer, L A Moyé, et al.
Circulation
|
December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators
R B Goldberg, M J Mellies, F M Sacks, et al.
The New England Journal of Medicine
|
January 23, 1997
Ventricular dysfunction and the risk of stroke after myocardial infarction
E Loh, M S Sutton, C C Wun, et al.
Heart (British Cardiac Society)
|
September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme
N M Hawkins, D Wang, J J V McMurray, et al.
Journal of the American College of Cardiology
|
July 21, 1998
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial
S J Lewis, F M Sacks, J S Mitchell, et al.
Journal of the American College of Cardiology
|
October 16, 1999
Hypertension detection, treatment and control: a call to action for cardiovascular specialists
D Levy, C N Merz, R J Cody, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 188) with videos related to
Sort By:
Page
of 19
Circulation
|
September 1, 1995
Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators
G A Lamas, G C Flaker, G Mitchell, et al.
The American Journal of Cardiology
|
March 15, 1995
Baseline characteristics in the Cholesterol and Recurrent Events (CARE) trial of secondary prevention in patients with average serum cholesterol levels
F M Sacks, J L Rouleau, L A Moye, et al.
Circulation
|
October 1, 1986
Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion
R G McKay, M A Pfeffer, R C Pasternak, et al.
Circulation
|
December 13, 1997
Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial
M St John Sutton, M A Pfeffer, L Moye, et al.
Circulation
|
October 1, 1994
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators
J D Rutherford, M A Pfeffer, L A Moyé, et al.
Circulation
|
December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators
R B Goldberg, M J Mellies, F M Sacks, et al.
The New England Journal of Medicine
|
January 23, 1997
Ventricular dysfunction and the risk of stroke after myocardial infarction
E Loh, M S Sutton, C C Wun, et al.
Heart (British Cardiac Society)
|
September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme
N M Hawkins, D Wang, J J V McMurray, et al.
Journal of the American College of Cardiology
|
July 21, 1998
Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial
S J Lewis, F M Sacks, J S Mitchell, et al.
Journal of the American College of Cardiology
|
October 16, 1999
Hypertension detection, treatment and control: a call to action for cardiovascular specialists
D Levy, C N Merz, R J Cody, et al.
Page
of 19